<p>隨着全球市場在複雜的環境中航行，小型股和價值股逐漸受到關注，投資者越來越多地關注亞洲那些不為人知的機會。儘管便士股票常常被視為過去交易日的遺物，但在強勁的財務支持下，它們仍然具有顯著增長的潛力。本文探討了三隻在資產負債表強度和發掘當前市場隱藏價值方面表現突出的亞洲便士股票。</p>
<h3>亞洲十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.44</td>
<td>HK$890.67M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.62</td>
<td>THB1.1B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.48</td>
<td>HK$2.06B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.122</td>
<td>SGD63.87M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Halcyon Technology (SET:HTECH)</td>
<td>THB2.96</td>
<td>THB888M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.45</td>
<td>SGD13.58B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Anton Oilfield Services Group (SEHK:3337)</td>
<td>HK$0.96</td>
<td>HK$2.54B</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.42</td>
<td>HK$19.55B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.53</td>
<td>HK$52.62B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們亞洲便士股票篩選器中的 947 只股票的完整列表。</p>
<p>以下是篩選器中一些選擇的預覽。</p>
<h2>LifeTech Scientific (SEHK:1302)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> LifeTech Scientific Corporation 是一家投資控股公司，專注於開發、製造和交易用於心血管和外周血管疾病的介入醫療設備，業務覆蓋中國大陸及多個國際市場，市值為 HK$83.8 億。</p>
<p><strong>運營：</strong> 公司的收入來自三個主要業務板塊：結構性心臟病業務（CN¥5.2787 億）、外周血管疾病業務（CN¥7.6208 億）和心臟起搏與電生理業務（CN¥3763 萬）。</p>
<p><strong>市值：</strong> HK$83.8 億</p>
<p>LifeTech Scientific 以 HK$83.8 億的市值因近期產品批准和介入醫療設備的創新而受到關注。該公司已獲得其 G-iliac™ Pro 支架系統和 CS™支架 - 移植物系統的監管批准，預計將顯著增強其產品組合。儘管過去五年盈利下降且近期出現負增長，LifeTech 仍然無債務，短期資產覆蓋負債的能力強。然而，管理層的任期有限可能在他們應對競爭激烈的行業動態和通過創新解決方案實現收入增長時帶來挑戰。</p>
<ul>
<li>點擊這裏發現 LifeTech Scientific 的細微差別，查看我們的詳細財務健康報告。</li>
<li>查看 LifeTech Scientific 的歷史業績報告，以瞭解其在過去幾年的表現。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f4cde0c9-3c8c-4906-8b2c-0faa80c9ae86/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f4cde0c9-3c8c-4906-8b2c-0faa80c9ae86/chart/debt-equity-history-analysis"/></p>
<p>截至 2026 年 1 月的 SEHK:1302 債務與股本歷史及分析</p>
<h2>United Energy Group (SEHK:467)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> United Energy Group Limited 是一家投資控股公司，涉及巴基斯坦、南亞、中東和北非的上游石油、天然氣、清潔能源和能源交易業務，市值約為 HK$124.1 億。</p>
<p><strong>運營：</strong> 該公司通過其交易業務產生的收入為 HK$79.9 億，勘探和生產活動的收入總計為 HK$91.3 億。</p>
<p><strong>市值：</strong> HK$124.1 億</p>
<p>United Energy Group 以 HK$124.1 億的市值，儘管過去五年盈利年均下降 19.2%，但最近已實現盈利。該公司受益於強大的現金儲備，超過其總債務，並且 EBIT 的利息覆蓋率為 44.4 倍，表明在波動性降低的情況下財務穩定。然而，挑戰包括管理團隊和董事會經驗不足，平均任期僅為 0.6 年，以及短期負債超過資產 HK$14 億，儘管盈利質量高，但股息未能得到盈利或自由現金流的良好覆蓋。</p>
<ul>
<li>點擊探索我們在 United Energy Group 財務健康報告中的詳細發現。</li>
<li>查看我們的歷史業績報告，以獲取關於 United Energy Group 的業績記錄的見解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2508be64-00a3-48b7-8fbc-63c2c5323748/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2508be64-00a3-48b7-8fbc-63c2c5323748/chart/debt-equity-history-analysis"/></p>
<p>截至 2026 年 1 月的 SEHK:467 債務與股本歷史及分析</p>
<h2>InnoTek (SGX:M14)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> InnoTek Limited 是一家投資控股公司，在香港、中國大陸、泰國和越南製造精密金屬組件，市值為 SGD172.63 百萬。</p>
<p><strong>運營：</strong> 公司的收入來自其 Mansfield 部門，精密加工收入為 SGD35.04 百萬，精密組件和工具收入為 SGD279.71 百萬。</p>
<p><strong>市值：</strong> SGD172.63 百萬</p>
<p>InnoTek Limited，市值為 1.7263 億新加坡元，展現出財務韌性，因為其現金儲備超過總債務，短期資產覆蓋長期和短期負債。然而，該公司面臨過去五年盈利下降的挑戰，股本回報率僅為 1.5%。儘管整體盈利質量較高，但股息支付並未得到盈利的良好支持。最近的董事會變動可能帶來戰略轉變，但並未立即解決盈利能力問題或改善淨利潤率，後者在過去一年中從 1.9% 降至 1.4%。</p>
<ul>
<li>點擊此鏈接查看 InnoTek 的完整分析健康報告，以深入瞭解該公司。</li>
<li>通過查看我們的業績歷史報告，瞭解 InnoTek 的過往表現。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12da91b7-f162-4c43-bee1-d9294ba5d487/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12da91b7-f162-4c43-bee1-d9294ba5d487/chart/debt-equity-history-analysis"/></p>
<p>截至 2026 年 1 月的 SGX:M14 債務與股本歷史及分析</p>
<h2>將想法轉化為行動</h2>
<ul>
<li>點擊此鏈接深入瞭解我們亞洲便士股票篩選器中的 947 家公司。</li>
<li>想要探索一些替代方案？通過提供可靠收入來源的穩健股息支付者來多樣化您的投資組合，以應對潛在的市場動盪。</li>
</ul>
<p><em>本文由 Simply Wall St 撰寫，內容具有一般性。<strong>我們基於歷史數據和分析師預測提供評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均沒有持倉。</em></p>

先健科技

利華控股集團

東江集團控股

<p>隨着全球市場的變化，投資者正關注亞洲的低價股票以尋求增長。本文重點介紹了三隻有前景的股票：利華控股集團（SEHK:1346），市值為 8.9067 億港元；亞洲醫學與農業實驗室（SET:AMARC），市值為 11 億泰銖；以及東江集團控股（SEHK:2283），市值為 20.6 億港元。每隻股票都顯示出強勁的財務狀況和價值發現的潛力。此外，先健科技（SEHK:1302）和聯合能源集團（SEHK:467）也被提及，市值分別為 83.8 億港元和 124.1 億港元，儘管面臨盈利和管理經驗方面的挑戰</p>

<p>As global markets navigate a mixed landscape, with small-cap and value stocks gaining traction, investors are increasingly looking toward under-the-radar opportunities in Asia. Penny stocks, though often considered a relic of past trading days, still hold potential for significant growth when backed by strong financials. In this article, we explore three Asian penny stocks that stand out for their balance sheet strength and potential to uncover hidden value in today's market.</p>
<div class="lb-trans"><p>隨着全球市場在複雜的環境中航行，小型股和價值股逐漸受到關注，投資者越來越多地關注亞洲那些不為人知的機會。儘管便士股票常常被視為過去交易日的遺物，但在強勁的財務支持下，它們仍然具有顯著增長的潛力。本文探討了三隻在資產負債表強度和發掘當前市場隱藏價值方面表現突出的亞洲便士股票。</p>
</div><h3>Top 10 Penny Stocks In Asia</h3>
<div class="lb-trans"><h3>亞洲十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.44</td>
<td>HK$890.67M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.62</td>
<td>THB1.1B</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.48</td>
<td>HK$2.06B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.122</td>
<td>SGD63.87M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Halcyon Technology (SET:HTECH)</td>
<td>THB2.96</td>
<td>THB888M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.45</td>
<td>SGD13.58B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Anton Oilfield Services Group (SEHK:3337)</td>
<td>HK$0.96</td>
<td>HK$2.54B</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.42</td>
<td>HK$19.55B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 View Analysis &gt;</td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.53</td>
<td>HK$52.62B</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.44</td>
<td>HK$890.67M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.62</td>
<td>THB1.1B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.48</td>
<td>HK$2.06B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.122</td>
<td>SGD63.87M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Halcyon Technology (SET:HTECH)</td>
<td>THB2.96</td>
<td>THB888M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.45</td>
<td>SGD13.58B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Anton Oilfield Services Group (SEHK:3337)</td>
<td>HK$0.96</td>
<td>HK$2.54B</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.42</td>
<td>HK$19.55B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.53</td>
<td>HK$52.62B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 947 stocks from our Asian Penny Stocks screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們亞洲便士股票篩選器中的 947 只股票的完整列表。</p>
</div><p>Here's a peek at a few of the choices from the screener.</p>
<div class="lb-trans"><p>以下是篩選器中一些選擇的預覽。</p>
</div><h2>LifeTech Scientific (SEHK:1302)</h2>
<div class="lb-trans"><h2>LifeTech Scientific (SEHK:1302)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> LifeTech Scientific Corporation is an investment holding company that develops, manufactures, and trades interventional medical devices for cardiovascular and peripheral vascular diseases across Mainland China and various international markets, with a market cap of HK$8.38 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> LifeTech Scientific Corporation 是一家投資控股公司，專注於開發、製造和交易用於心血管和外周血管疾病的介入醫療設備，業務覆蓋中國大陸及多個國際市場，市值為 HK$83.8 億。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from three main segments: Structural Heart Diseases Business (CN¥527.87 million), Peripheral Vascular Diseases Business (CN¥762.08 million), and Cardiac Pacing and Electrophysiology Business (CN¥37.63 million).</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入來自三個主要業務板塊：結構性心臟病業務（CN¥5.2787 億）、外周血管疾病業務（CN¥7.6208 億）和心臟起搏與電生理業務（CN¥3763 萬）。</p>
</div><p><strong>Market Cap:</strong> HK$8.38B</p>
<div class="lb-trans"><p><strong>市值：</strong> HK$83.8 億</p>
</div><p>LifeTech Scientific, with a market cap of HK$8.38 billion, is gaining attention due to recent product approvals and innovations in interventional medical devices. The company has secured regulatory approval for its G-iliac™ Pro stent system and the CS™ Stent-Graft System, which are expected to enhance its product portfolio significantly. Despite a decline in earnings over the past five years and recent negative growth, LifeTech remains debt-free with strong short-term asset coverage over liabilities. However, management's limited tenure may pose challenges as they navigate competitive industry dynamics and aim for revenue growth through innovative solutions.</p>
<div class="lb-trans"><p>LifeTech Scientific 以 HK$83.8 億的市值因近期產品批准和介入醫療設備的創新而受到關注。該公司已獲得其 G-iliac™ Pro 支架系統和 CS™支架 - 移植物系統的監管批准，預計將顯著增強其產品組合。儘管過去五年盈利下降且近期出現負增長，LifeTech 仍然無債務，短期資產覆蓋負債的能力強。然而，管理層的任期有限可能在他們應對競爭激烈的行業動態和通過創新解決方案實現收入增長時帶來挑戰。</p>
</div><ul>
<li>Click here to discover the nuances of LifeTech Scientific with our detailed analytical financial health report.</li>
<li>Examine LifeTech Scientific's past performance report to understand how it has performed in prior years.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏發現 LifeTech Scientific 的細微差別，查看我們的詳細財務健康報告。</li>
<li>查看 LifeTech Scientific 的歷史業績報告，以瞭解其在過去幾年的表現。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f4cde0c9-3c8c-4906-8b2c-0faa80c9ae86/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/f4cde0c9-3c8c-4906-8b2c-0faa80c9ae86/chart/debt-equity-history-analysis"/></p>
<p>SEHK:1302 Debt to Equity History and Analysis as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 SEHK:1302 債務與股本歷史及分析</p>
</div><h2>United Energy Group (SEHK:467)</h2>
<div class="lb-trans"><h2>United Energy Group (SEHK:467)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> United Energy Group Limited is an investment holding company involved in upstream oil, natural gas, clean energy, and energy trading operations across Pakistan, South Asia, the Middle East, and North Africa with a market cap of approximately HK$12.41 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> United Energy Group Limited 是一家投資控股公司，涉及巴基斯坦、南亞、中東和北非的上游石油、天然氣、清潔能源和能源交易業務，市值約為 HK$124.1 億。</p>
</div><p><strong>Operations:</strong> The company generates revenue from its trading operations amounting to HK$7.99 billion and exploration and production activities totaling HK$9.13 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司通過其交易業務產生的收入為 HK$79.9 億，勘探和生產活動的收入總計為 HK$91.3 億。</p>
</div><p><strong>Market Cap:</strong> HK$12.41B</p>
<div class="lb-trans"><p><strong>市值：</strong> HK$124.1 億</p>
</div><p>United Energy Group, with a market cap of HK$12.41 billion, has recently become profitable despite a 19.2% annual decline in earnings over the past five years. The company benefits from strong cash reserves exceeding its total debt and robust interest coverage of 44.4 times EBIT, indicating financial stability amidst volatility reduction from 10% to 5%. However, challenges include an inexperienced management team and board with an average tenure of just 0.6 years, alongside short-term liabilities surpassing assets by HK$1.4 billion and a dividend not well covered by earnings or free cash flows despite high-quality earnings.</p>
<div class="lb-trans"><p>United Energy Group 以 HK$124.1 億的市值，儘管過去五年盈利年均下降 19.2%，但最近已實現盈利。該公司受益於強大的現金儲備，超過其總債務，並且 EBIT 的利息覆蓋率為 44.4 倍，表明在波動性降低的情況下財務穩定。然而，挑戰包括管理團隊和董事會經驗不足，平均任期僅為 0.6 年，以及短期負債超過資產 HK$14 億，儘管盈利質量高，但股息未能得到盈利或自由現金流的良好覆蓋。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in United Energy Group's financial health report.</li>
<li>Review our historical performance report to gain insights into United Energy Group's track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊探索我們在 United Energy Group 財務健康報告中的詳細發現。</li>
<li>查看我們的歷史業績報告，以獲取關於 United Energy Group 的業績記錄的見解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2508be64-00a3-48b7-8fbc-63c2c5323748/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/2508be64-00a3-48b7-8fbc-63c2c5323748/chart/debt-equity-history-analysis"/></p>
<p>SEHK:467 Debt to Equity History and Analysis as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 SEHK:467 債務與股本歷史及分析</p>
</div><h2>InnoTek (SGX:M14)</h2>
<div class="lb-trans"><h2>InnoTek (SGX:M14)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> InnoTek Limited is an investment holding company that manufactures precision metal components in Hong Kong, the People’s Republic of China, Thailand, and Vietnam, with a market cap of SGD172.63 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> InnoTek Limited 是一家投資控股公司，在香港、中國大陸、泰國和越南製造精密金屬組件，市值為 SGD172.63 百萬。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from its Mansfield division, with SGD35.04 million from Precision Machining and SGD279.71 million from Precision Components and Tooling.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入來自其 Mansfield 部門，精密加工收入為 SGD35.04 百萬，精密組件和工具收入為 SGD279.71 百萬。</p>
</div><p><strong>Market Cap:</strong> SGD172.63M</p>
<div class="lb-trans"><p><strong>市值：</strong> SGD172.63 百萬</p>
</div><p>InnoTek Limited, with a market cap of SGD172.63 million, demonstrates financial resilience as its cash reserves exceed total debt and short-term assets cover both long-term and short-term liabilities. However, the company faces challenges with declining earnings over the past five years and low return on equity at 1.5%. The dividend payout is not well covered by earnings despite high-quality earnings overall. Recent board changes may bring strategic shifts but do not immediately address profitability concerns or improve net profit margins, which have decreased from 1.9% to 1.4% over the last year.</p>
<div class="lb-trans"><p>InnoTek Limited，市值為 1.7263 億新加坡元，展現出財務韌性，因為其現金儲備超過總債務，短期資產覆蓋長期和短期負債。然而，該公司面臨過去五年盈利下降的挑戰，股本回報率僅為 1.5%。儘管整體盈利質量較高，但股息支付並未得到盈利的良好支持。最近的董事會變動可能帶來戰略轉變，但並未立即解決盈利能力問題或改善淨利潤率，後者在過去一年中從 1.9% 降至 1.4%。</p>
</div><ul>
<li>Jump into the full analysis health report here for a deeper understanding of InnoTek.</li>
<li>Understand InnoTek's track record by examining our performance history report.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊此鏈接查看 InnoTek 的完整分析健康報告，以深入瞭解該公司。</li>
<li>通過查看我們的業績歷史報告，瞭解 InnoTek 的過往表現。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12da91b7-f162-4c43-bee1-d9294ba5d487/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/12da91b7-f162-4c43-bee1-d9294ba5d487/chart/debt-equity-history-analysis"/></p>
<p>SGX:M14 Debt to Equity History and Analysis as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 SGX:M14 債務與股本歷史及分析</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>將想法轉化為行動</h2>
</div><ul>
<li>Click this link to deep-dive into the 947 companies within our Asian Penny Stocks screener.</li>
<li>Want To Explore Some Alternatives? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊此鏈接深入瞭解我們亞洲便士股票篩選器中的 947 家公司。</li>
<li>想要探索一些替代方案？通過提供可靠收入來源的穩健股息支付者來多樣化您的投資組合，以應對潛在的市場動盪。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰寫，內容具有一般性。<strong>我們基於歷史數據和分析師預測提供評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均沒有持倉。</em></p>
</div>

三隻市值低於 20 億美元的亞洲便士股